Physician profile
Benjamin David Leaver
NPI 1508925033
$2,393.39
in general payments reported to CMS, 2019-2025
10 companies · $687 in 2025
The $687 reported for 2025 was more than what 93% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.22 · 2020: $661 · 2021: $151 · 2022: $329 · 2023: $83.41 · 2024: $407 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Gift: $406 · Education: $13.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.88 |
| Gift | $405.96 |
| Education | $13.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $673.64 | 2019-2025 | Opalescence |
| Straumann USA LLC | $644.60 | 2024-2025 | |
| A-Dec, INC. | $574.00 | 2020 | |
| Biohorizons Implant Systems INC. | $194.89 | 2020-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply Sirona INC | $91.82 | 2019-2023 | Cerec |
| Zimmer Biomet Holdings, INC. | $90.47 | 2021 | |
| 3m Company | $44.39 | 2022 | |
| Nobel Biocare USA | $35.81 | 2019-2023 | Nobelactive |
| Implant Direct Sybron International LLC | $30.43 | 2022 | |
| Gc America INC. | $13.34 | 2023 | Initial Lisi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Leaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.